Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds
March 21, 2019 Off

Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds

By BusinessWire

SAN FRANCISCO–(BUSINESS WIRE)–Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million…

Ligand to Receive Milestone and Royalties as Result of FDA Approval of Sage Therapeutics’ ZULRESSO™ (brexanolone) Injection
March 21, 2019 Off

Ligand to Receive Milestone and Royalties as Result of FDA Approval of Sage Therapeutics’ ZULRESSO™ (brexanolone) Injection

By BusinessWire

ZULRESSO is the first and only treatment specifically indicated for postpartum depression SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced…

Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors
March 21, 2019 Off

Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors

By BusinessWire

BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced the nominations of Shawn Cline…

March 21, 2019 Off

$1.69 Bn Pharmaceutical Drug Delivery Market by Route and Application – Global Forecast to 2023 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Drug Delivery Market by Route and Application – Global Forecast to 2023” report has been added to…

March 21, 2019 Off

Novocure Announces 48 Presentations and a Symposium Session on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2019

By BusinessWire

A special symposium session, intended to highlight therapeutic advances, will focus on Tumor Treating Fields as a fourth modality in…

March 21, 2019 Off

Novocure’s Chief Science Officer Retires after 17 Years of Service

By BusinessWire

ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) today announced the retirement of Dr. Eilon Kirson, Novocure’s Chief Science Officer and Head…

Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial in Japan Designed to Support Requirements for Future Regulatory Filing
March 21, 2019 Off

Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial in Japan Designed to Support Requirements for Future Regulatory Filing

By BusinessWire

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class…

Rare Diseases: PKU GOLIKE® Debuts in Germany
March 21, 2019 Off

Rare Diseases: PKU GOLIKE® Debuts in Germany

By BusinessWire

BALERNA, Switzerland–(BUSINESS WIRE)–PKU GOLIKE®, the brand new generation of Phenylalanine (PHe)-free medical food for Phenylketonuria (PKU) dietary management, is now…

March 21, 2019 Off

Innovus Pharmaceuticals Reports Preliminary Annual 2018 Net Revenue of $24 Million

By BusinessWire

Preliminary Annual Revenue Increase by 2.7x Compared to Prior Year SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”)…

March 21, 2019 Off

Modra Pharmaceuticals Announces First Patients Treated in Phase IIa Metastatic Breast Cancer Trial

By BusinessWire

–Study will test efficacy and safety of novel docetaxel-based oral therapeutic– AMSTERDAM–(BUSINESS WIRE)–Modra Pharmaceuticals B.V. (“Modra”) today announced that the…

Posts pagination

Previous 1 … 3,340 3,341 3,342 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine